» Articles » PMID: 24391758

Ultra-deep Pyrosequencing (UDPS) Data Treatment to Study Amplicon HCV Minor Variants

Overview
Journal PLoS One
Date 2014 Jan 7
PMID 24391758
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

We have investigated the reliability and reproducibility of HCV viral quasispecies quantification by ultra-deep pyrosequencing (UDPS) methods. Our study has been divided in two parts. First of all, by UDPS sequencing of clone mixes samples we have established the global noise level of UDPS and fine tuned a data treatment workflow previously optimized for HBV sequence analysis. Secondly, we have studied the reproducibility of the methodology by comparing 5 amplicons from two patient samples on three massive sequencing platforms (FLX+, FLX and Junior) after applying the error filters developed from the clonal/control study. After noise filtering the UDPS results, the three replicates showed the same 12 polymorphic sites above 0.7%, with a mean CV of 4.86%. Two polymorphic sites below 0.6% were identified by two replicates and one replicate respectively. A total of 25, 23 and 26 haplotypes were detected by GS-Junior, GS-FLX and GS-FLX+. The observed CVs for the normalized Shannon entropy (Sn), the mutation frequency (Mf), and the nucleotidic diversity (Pi) were 1.46%, 3.96% and 3.78%. The mean absolute difference in the two patients (5 amplicons each), in the GS-FLX and GS-FLX+, were 1.46%, 3.96% and 3.78% for Sn, Mf and Pi. No false polymorphic site was observed above 0.5%. Our results indicate that UDPS is an optimal alternative to molecular cloning for quantitative study of HCV viral quasispecies populations, both in complexity and composition. We propose an UDPS data treatment workflow for amplicons from the RNA viral quasispecies which, at a sequencing depth of at least 10,000 reads per strand, enables to obtain sequences and frequencies of consensus haplotypes above 0.5% abundance with no erroneous mutations, with high confidence, resistant mutants as minor variants at the level of 1%, with high confidence that variants are not missed, and highly confident measures of quasispecies complexity.

Citing Articles

Virus Quasispecies Rarefaction: Subsampling with or without Replacement?.

Gregori J, Ibanez-Lligona M, Colomer-Castell S, Campos C, Quer J Viruses. 2024; 16(5).

PMID: 38793592 PMC: 11126021. DOI: 10.3390/v16050710.


Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV Patient.

Gregori J, Colomer-Castell S, Campos C, Ibanez-Lligona M, Garcia-Cehic D, Rando-Segura A Int J Mol Sci. 2022; 23(23).

PMID: 36498981 PMC: 9739305. DOI: 10.3390/ijms232314654.


Ultra Deep Sequencing of Circulating Cell-Free DNA as a Potential Tool for Hepatocellular Carcinoma Management.

Higuera M, Vargas-Accarino E, Torrens M, Gregori J, Salcedo M, Martinez-Camprecios J Cancers (Basel). 2022; 14(16).

PMID: 36010868 PMC: 9406074. DOI: 10.3390/cancers14163875.


Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3' End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients.

Garcia-Garcia S, Caballero-Garralda A, Tabernero D, Cortese M, Gregori J, Rodriguez-Algarra F Biomedicines. 2022; 10(5).

PMID: 35625929 PMC: 9139148. DOI: 10.3390/biomedicines10051194.


Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients.

Llorens-Revull M, Gregori J, Dopazo C, Rodriguez-Frias F, Garcia-Cehic D, Soria M Genes (Basel). 2021; 12(11).

PMID: 34828337 PMC: 8625210. DOI: 10.3390/genes12111731.


References
1.
Vandenbroucke I, Van Marck H, Verhasselt P, Thys K, Mostmans W, Dumont S . Minor variant detection in amplicons using 454 massive parallel pyrosequencing: experiences and considerations for successful applications. Biotechniques. 2011; 51(3):167-77. DOI: 10.2144/000113733. View

2.
Flaherty P, Natsoulis G, Muralidharan O, Winters M, Buenrostro J, Bell J . Ultrasensitive detection of rare mutations using next-generation targeted resequencing. Nucleic Acids Res. 2011; 40(1):e2. PMC: 3245950. DOI: 10.1093/nar/gkr861. View

3.
Zagordi O, Bhattacharya A, Eriksson N, Beerenwinkel N . ShoRAH: estimating the genetic diversity of a mixed sample from next-generation sequencing data. BMC Bioinformatics. 2011; 12:119. PMC: 3113935. DOI: 10.1186/1471-2105-12-119. View

4.
Huse S, Huber J, Morrison H, Sogin M, Welch D . Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol. 2007; 8(7):R143. PMC: 2323236. DOI: 10.1186/gb-2007-8-7-r143. View

5.
Ramirez C, Gregori J, Buti M, Tabernero D, Camos S, Casillas R . A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a model. Antiviral Res. 2013; 98(2):273-83. DOI: 10.1016/j.antiviral.2013.03.007. View